Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Psychosis in medical conditions: response to risperidone.

Furmaga KM, DeLeon OA, Sinha SB, Jobe TH, Gaviria M.

Gen Hosp Psychiatry. 1997 May;19(3):223-8.

PMID:
9218991
2.

Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.

J Clin Psychiatry. 2001 Aug;62(8):623-30.

PMID:
11561935
3.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
4.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

5.

Risperidone in the treatment of delirium: results from a prospective open-label trial.

Mittal D, Jimerson NA, Neely EP, Johnson WD, Kennedy RE, Torres RA, Nasrallah HA.

J Clin Psychiatry. 2004 May;65(5):662-7.

PMID:
15163252
6.

The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.

Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.

Int J Geriatr Psychiatry. 2007 May;22(5):475-84.

PMID:
17471598
7.

Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia.

Rainer MK, Masching AJ, Ertl MG, Kraxberger E, Haushofer M.

J Clin Psychiatry. 2001 Nov;62(11):894-900.

PMID:
11775050
8.

Risperidone in the treatment of patients with delirium.

Parellada E, Baeza I, de Pablo J, Martínez G.

J Clin Psychiatry. 2004 Mar;65(3):348-53.

PMID:
15096074
9.

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M.

J Clin Psychiatry. 1999 Feb;60(2):107-15.

PMID:
10084637
11.
12.

Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders.

Lai YC, Huang MC, Chen CH, Tsai CJ, Pan CH, Chiu CC.

Psychiatry Clin Neurosci. 2009 Aug;63(4):440-8. doi: 10.1111/j.1440-1819.2009.01977.x. Epub 2009 Apr 27.

13.

Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients.

Jung SM, Kim KA, Cho HK, Jung IG, Park PW, Byun WT, Park JY.

Clin Pharmacol Ther. 2005 Nov;78(5):520-8. Epub 2005 Sep 26.

PMID:
16321618
14.

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.

J Clin Psychiatry. 2003 Feb;64(2):134-43.

PMID:
12633121
15.

Risperidone in acute and continuation treatment of mania.

Yatham LN, Binder C, Riccardelli R, Leblanc J, Connolly M, Kusumakar V; RIS-CAN 25 Study Group.

Int Clin Psychopharmacol. 2003 Jul;18(4):227-35.

PMID:
12817157
16.

Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels.

Lane HY, Chiu WC, Chou JC, Wu ST, Su MH, Chang WH.

J Clin Psychiatry. 2000 Mar;61(3):209-14.

PMID:
10817107
17.

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.

Davidson M, Harvey PD, Vervarcke J, Gagiano CA, De Hooge JD, Bray G, Dose M, Barak Y, Haushofer M.

Int J Geriatr Psychiatry. 2000 Jun;15(6):506-14.

PMID:
10861916
18.
19.
20.

Supplemental Content

Support Center